logo
HIV prevention funding; Wisconsin could feel big cuts

HIV prevention funding; Wisconsin could feel big cuts

Yahoo25-03-2025

The Brief
The Trump administration is weighing cuts to eliminate the CDC's Division of HIV Prevention.
Vivent Health is the second-largest provider of HIV prevention and treatment services in the nation.
Wisconsin gets $1.2 million in prevention efforts, making it one of the hardest-hit states.
MILWAUKEE - The Trump administration is weighing cuts to eliminate the Division of HIV Prevention at the Centers for Disease Control and Prevention (CDC) and reduce federal funding for HIV prevention programs.
What we know
According to Vivent Health, which has grown to be the second-largest provider of HIV prevention care in the nation, the proposal could cut more than $1.3 billion in HIV testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) navigation, syringe service programs (SSPs), and other prevention services.
Vivent Health receives $5,375,000 in annual funding for programs in six states; $1.2 million helps with prevention efforts in Wisconsin, making it one of the hardest-hit states.
Dig deeper
In Wisconsin, 73% of Vivent Health patients live at or below the Federal Poverty Line, and 75% have no insurance or rely on Medicaid or Medicare. According to the Wisconsin Department of Health Services, as of 2023, there were more than 7,300 people living with HIV in the state – and over half of people living with HIV in Wisconsin reside in Milwaukee and Dane counties.
Local perspective
For over two decades, Gregory León has been living with HIV. The chef and owner of the nationally recognized Amilinda said he wants to use his platform to fight the stigma.
He's concerned about President Donald Trump's administration's potential cuts.
"It's not something people should be ashamed of [...] We all know one person that is HIV-positive. We might not know that they are, but I'm sure in our daily lives," León said. "With their cuts, it is going to impact primarily the poor, the unhoused, people of color, the trans community, the more marginalized parts of the LGBTQ community and of society."
Why you should care
Reports indicate the tentative proposal would merge the program with a unit within the Department of Health and Human Services, changes León said could potentially cost lives.
"At the end of the day, you're going to create a horrific situation, not only in the United States, but all over the world where people are going to be contracting AIDS and dying, and you want to prevent that," he said.
What they're saying
Vivent Health released the following statement from Chief Advocacy Officer Bill Keeton:
"Not only would this proposal end a critical source of funding that is central to efforts to provide people most impacted by and vulnerable to HIV with life-saving medication, education and resources, but it will also ultimately raise the cost of health care for all Americans. The lifetime average costs associated with HIV care and treatment for individuals who acquire HIV are estimated at $500,000 over the course of their lifetime – a cost that will be spread across public and private insurance, healthcare systems, taxpayers and American healthcare consumers. This fact alone makes this proposal not only an affront to health, but a poor financial decision as well."
The other side
FOX6 News reached out to the Republican Party of Wisconsin but did not hear back.
The Source
Data comes from Vivent Health and the Wisconsin Department of Health Services.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Can I donate blood and how do I do it? Urgent call for donors amid low stocks
Can I donate blood and how do I do it? Urgent call for donors amid low stocks

Yahoo

time21 minutes ago

  • Yahoo

Can I donate blood and how do I do it? Urgent call for donors amid low stocks

The NHS needs 200,000 more regular blood donors to sustain a safe and sufficient supply. Low blood stocks in 2024 prompted an "amber alert', but blood stocks have remained low ever since. NHS Blood and Transplant (NHSBT) is now urging more people to donate to avoid a "red alert", which is a critical situation where public safety is threatened. It described the past year as "challenging" for blood stocks, noting that just under 800,000 people are supporting the entire blood supply in England. The whole process of giving blood takes just one hour. When arriving at a blood donation centre, you are asked to complete a safety check to make sure you can give blood. You will be given 500ml of fluid to drink – drinking this will help the body maintain blood pressure, prevent dizziness and help the body replenish the donated blood. Then, to ensure it is safe to donate blood, medics will confirm your identity and information in your health check. In some cases, a registered nurse will follow up. A drop of blood from your finger is then checked for iron levels. If these levels are too low, the appointment will be rescheduled. Those able to donate will be seated in the waiting area before being called to a donation chair. Here, a cuff will be placed on your arm to maintain a small amount of pressure during the donation before a suitable vein is found and the area is cleaned. Then, a needle will be inserted into your arm to collect your blood into a blood bag, which has your unique donor number on it. A scale weighs the blood and stops when you have donated 470ml - that's just under a pint. The needle is then removed from your arm, and a dressing is applied. The NHS says the process of giving blood should not hurt and should only take about 10 minutes. Although more donors are needed, there are some health, travel and lifestyle reasons that may stop you from donating blood. Donors need to be fit and well, aged between 17 and 65, weigh between 7 stone 12 Ibs (50kg) and 25 stone (158kg) and have suitable veins. However, you can't donate blood if you have cancer, some heart conditions, have tested positive for HIV or are a hepatitis B or C carrier. If you have received blood platelets, plasma or any other blood products after January 1980, or if you have injected non-prescribed drugs including body-building and injectable tanning agents, you also cannot donate. If you've had anal sex with a new partner in the last three months you may have to postpone your donation. If you feel unwell, are pregnant or have had a baby in the last six months, have had a tattoo or piercing, or have recently travelled to certain countries outside the UK, you may also have to wait before you can donate blood. There are thousands of blood donation venues across England, some are permanent and others are pop-ups. Church halls, sports centres, mosques, football stadiums and hotels are all used as pop-up venues. To check where your closest one is, visit the Give Blood website. You will need to book an appointment ahead of your donation which can be done online as soon as you have signed up as a blood donor. There is a 'critical' need for more donors who have the so-called universal blood type, O negative blood, which is needed for treatment in emergencies. The NHS said there is also a need for more Black donors, who are more likely to have specific blood types which can help treat people with sickle cell disease.

NIH scientists condemn Trump research cuts
NIH scientists condemn Trump research cuts

Yahoo

time29 minutes ago

  • Yahoo

NIH scientists condemn Trump research cuts

Hundreds of staffers from across the National Institutes of Health (NIH) are speaking out against the politicization of their research and termination of their work while demanding that the drastic changes made at the agency be walked back. In a letter addressed to NIH Director Jay Bhattacharya, more than 2,000 signatories stated, 'we dissent to Administration policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' The letter was titled 'The Bethesda Declaration' in reference to where NIH's campus is located. The signatories cited Bhattacharya's stated commitment to academic freedom that he made in April and called on him to push back against the changes Trump administration has implemented at NIH under his leadership. 'Academic freedom should not be applied selectively based on political ideology. To achieve political aims, NIH has targeted multiple universities with indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' they wrote. They pointed to U.S. law and prior research that has shown that the participation of diverse populations in studies is necessary for NIH's work. The NIH staffers further blasted the canceling of nearly completed studies. 'Ending a $5 million research study when it is 80% complete does not save $1 million, it wastes $4 million,' they wrote. The researchers called on Bhattacharya to restore foreign collaborations with the global scientific community, put independent peer reviews back in place, bring back terminated NIH staffers and rethink the 15 percent cap on indirect study costs that the Trump administration enacted. 'Combined, these actions have resulted in an unprecedented reduction in NIH spending that does not reflect efficiency but rather a dramatic reduction in life-saving research,' they stated. 'Some may use the false impression that NIH funding is not needed to justify the draconian cuts proposed in the President's Budget. This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research.' NIH research is not solely centered in Bethesda. The agency is responsible for funding research projects across the country and abroad. Numerous lawsuits have been filed to combat the pulling back of billions of dollars in NIH funding. Last week, a federal judge allowed a suit filed by university researchers and public health groups challenging the cuts to move forward. Bhattacharya responded to the letter on the social media platform X. 'We all want @NIH to succeed and I believe that dissent in science is productive. However, the Bethesda Declaration has some fundamental misconceptions about the policy directions NIH has taken in recent months,' he wrote. Bhattacharya said the actions taken at NIH have been to 'remove ideological influence from science' and further argued the agency hasn't halted international scientific collaboration but is instead 'ensuring accountability.' 'Claims that NIH is undermining peer review are misunderstood. We're expanding access to publishing while strengthening transparency, rigor, and reproducibility in NIH-funded research,' he wrote. 'Lastly, we are reviewing each termination case carefully and some individuals have already been reinstated. As NIH priorities evolve, so must our staffing to stay mission-focused and responsibly manage taxpayer dollars.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Why Universal Health Services (UHS) Shares Are Trading Lower Today
Why Universal Health Services (UHS) Shares Are Trading Lower Today

Yahoo

time38 minutes ago

  • Yahoo

Why Universal Health Services (UHS) Shares Are Trading Lower Today

Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.7% in the afternoon session after Chief Financial Officer Steve Filton noted during a recent conference that procedural volumes (an important driver of hospital revenue) "have been slower to recover back to historical levels than we might have imagined." Filton also voiced concern over the Trump administration's proposed federal spending bill, particularly its implications for healthcare funding. Since UHS derives a significant portion of its revenue from government programs like Medicare and Medicaid, the anticipated cuts to Medicaid could significantly affect the company, especially in regions with high dependency on public healthcare funding. The shares closed the day at $177.76, down 6.2% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Universal Health Services? Access our full analysis report here, it's free. Universal Health Services's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 28 days ago when the stock gained 5.9% after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. Universal Health Services is down 1.1% since the beginning of the year, and at $177.77 per share, it is trading 26.4% below its 52-week high of $241.52 from September 2024. Investors who bought $1,000 worth of Universal Health Services's shares 5 years ago would now be looking at an investment worth $1,628. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store